← Open Payments lookup

THOMAS OSINOWO: Open Payments

NPI 1518044585 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,089 in 47 payments from 13 companies in 2025. Trend: 2023 $563 · 2024 $466 · 2025 $1,089

Food & beverage: $1,089
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$254
ABBVIE INC.10$253
E.R. Squibb & Sons, L.L.C.11$156
Vanda Pharmaceuticals Inc.3$73
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$72
Otsuka America Pharmaceutical, Inc.3$67
Alkermes, Inc.2$48
Teva Pharmaceuticals USA, Inc.2$36
Lundbeck LLC2$34
Axsome Therapeutics, Inc.1$29

Products named: INGREZZA, VRAYLAR, COBENFY, HETLIOZ, CAPLYTA, REXULTI, ARISTADA, ABILIFY MAINTENA.

Industry payments across MI — which companies pay providers there.